Disclosed is a formulation for targeting an epitope on an antigen expressed in a mammal. The formulation comprises a pharmaceutically acceptable carrier together with a dimeric biosynthetic construct for binding at least one preselected antigen. The biosynthetic construct contains two polypeptide chains,...http://www.google.fr/patents/US5534254?utm_source=gb-gplus-shareBrevet US5534254 - Biosynthetic binding proteins for immuno-targeting
Biosynthetic binding proteins for immuno-targeting
